| Product |
CAS |
Molecular formula |
More |
| 2-((Piperidin-2-ylmethyl)sulfinyl)pyrazine hydrochloride |
1420805-43-1 |
C10H16ClN3OS |
More |
| 2-((Piperidin-3-ylmethyl)sulfinyl)pyrazine hydrochloride |
1420805-52-2 |
C10H16ClN3OS |
More |
| 2-((Piperidin-4-ylmethyl)sulfinyl)pyrazine hydrochloride |
1420889-47-9 |
C10H16ClN3OS |
More |
| 2-(Pyrrolidin-3-ylsulfinyl)pyrazine hydrochloride |
1420869-75-5 |
C8H12ClN3OS |
More |
| 2-((S)-((r)-pyrrolidin-3-yl)sulfinyl)pyrazine hydrochloride |
1421054-98-9 |
C8H12ClN3OS |
More |
| 2-((R)-((s)-pyrrolidin-3-yl)sulfinyl)pyrazine hydrochloride |
1421055-59-5 |
C8H12ClN3OS |
More |
| 2-((Pyrrolidin-2-ylmethyl)sulfinyl)pyrazine hydrochloride |
1420889-56-0 |
C9H14ClN3OS |
More |
| 2-((Pyrrolidin-3-ylmethyl)sulfinyl)pyrazine hydrochloride |
1420838-74-9 |
C9H14ClN3OS |
More |
| Tert-butyl 3-(pyrazin-2-ylsulfonyl)piperidine-1-carboxylate |
1420887-09-7 |
C14H21N3O4S |
More |
| Tert-butyl 4-(pyrazin-2-ylsulfonyl)piperidine-1-carboxylate |
1420894-50-3 |
C14H21N3O4S |
More |
| Tert-butyl 2-((pyrazin-2-ylsulfonyl)methyl)piperidine-1-carboxylate |
1420869-87-9 |
C15H23N3O4S |
More |
| Tert-butyl 3-((pyrazin-2-ylsulfonyl)methyl)piperidine-1-carboxylate |
1421003-31-7 |
C15H23N3O4S |
More |
| Tert-butyl 4-((pyrazin-2-ylsulfonyl)methyl)piperidine-1-carboxylate |
1420828-02-9 |
C15H23N3O4S |
More |
| Tert-butyl 3-(pyrazin-2-ylsulfonyl)pyrrolidine-1-carboxylate |
1420872-03-2 |
C13H19N3O4S |
More |
| (R)-tert-butyl 3-(pyrazin-2-ylsulfonyl)pyrrolidine-1-carboxylate |
1421027-74-8 |
C13H19N3O4S |
More |
| (S)-tert-butyl 3-(pyrazin-2-ylsulfonyl)pyrrolidine-1-carboxylate |
1421010-05-0 |
C13H19N3O4S |
More |
| Tert-butyl 2-((pyrazin-2-ylsulfonyl)methyl)pyrrolidine-1-carboxylate |
1420872-10-1 |
C14H21N3O4S |
More |
| Tert-butyl 3-((pyrazin-2-ylsulfonyl)methyl)pyrrolidine-1-carboxylate |
1420869-95-9 |
C14H21N3O4S |
More |
| 2-(Piperidin-3-ylsulfonyl)pyrazine hydrochloride |
1420870-01-4 |
C9H14ClN3O2S |
More |
| 2-(Piperidin-4-ylsulfonyl)pyrazine hydrochloride |
1420970-15-5 |
C9H14ClN3O2S |
More |
